«
»

Top

J&J Ordered To Pay $4.69 In Damages In Talc Cancer Case

Jul 18, 2018

J&J Ordered To Pay $4.69 In Damages In Talc Cancer Case

US pharmaceutical giant Johnson & Johnson was Thursday ordered to pay out $4.69 billion in damages in a lawsuit representing 22 women and their families who alleged a talc sold by the company contained asbestos and caused them to suffer cancer.

It is the latest twist in a matter that has seen several thousand lawsuits filed against J&J. According to the victims' lawyer, Mark Lanier, a jury composed of six men and six women in St Louis, Missouri, ruled in favor of the women after a six-week trial and eight hours of deliberation. The damages include $550 million in compensation and over $4.1 billion in punitive damages. The plaintiffs said using the talc for personal hygiene had caused ovarian cancer.

"For over 40 years, Johnson & Johnson has covered up the evidence of asbestos in their products," Lanier said in a statement. "We hope this verdict will get the attention of the J&J board and that it will lead them to better inform the medical community and the public about the connection between asbestos, talc, and ovarian cancer," he said, calling for 
talc to be pulled from the market.

J&J said it was "deeply disappointed in the verdict." In a statement, it described the trial as "a fundamentally unfair process 
that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer."

"The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding." The company said its talc does not contain asbestos or cause ovarian cancer, and vowed it would "pursue all available appellate remedies."

Several similar trials have already taken place, with a Los Angeles appeals court last October dismissing a $417 million verdict against J&J, saying the complainant's arguments were insufficient and vague.

Comments

You will also like

World Cancer Day: Facts and Insights!

Bladder cancer
Brain tumor
Breast cancer
Cancer
Cancer of the Pleura
Cancer of the vulva
Cervical cancer
Colon cancer
Colorectal cancer
Endocrine cancer
Endometrial cancer
Esophageal cancer
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumor
Larynx cancer
Leiomyosarcoma
Liver cancer
Neuroendocrine liver cancer
Neuroendocrine tumor
Ovarian cancer
Pancreatic cancer
Testicular cancer
Thymus cancer
Thyroid Cancer

World Cancer Day: Facts and Insights!

Read the article
Telling patients to 'fight' cancer puts them under pressure

Bladder cancer
Brain tumor
Breast cancer
Cancer of the Pleura
Cancer of the vulva
Cervical cancer
Colorectal cancer
Endometrial cancer
Esophageal cancer
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumor
Larynx cancer
Liver cancer
Neuroendocrine tumor
Ovarian cancer
Pancreatic cancer
Prostate cancer
Testicular cancer
Thymus cancer
Thyroid Cancer

Telling patients to 'fight' cancer puts them under pressure

Read the article
Breast Cancer diagnosis: Carenity members tell their story

Breast cancer
Cancer

Breast Cancer diagnosis: Carenity members tell their story

Read the article
Cancer Diagnosis: Carenity Members Tell Their Story

Bladder cancer
Breast cancer
Cancer
Cancer of the Pleura
Cancer of the vulva
Cervical cancer
Colon cancer
Colorectal cancer
Endocrine cancer
Endometrial cancer
Esophageal cancer
Gallbladder cancer
Gastric cancer
Larynx cancer
Liver cancer
Neuroendocrine liver cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Small cell lung cancer
Testicular cancer
Thymus cancer
Thyroid Cancer

Cancer Diagnosis: Carenity Members Tell Their Story

Read the article